Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Rapid Dose Therapeutics Corp C.DOSE

Alternate Symbol(s):  RDTCF

Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream... see more

CSE:DOSE - Post Discussion

View:
Post by lscfa on Mar 10, 2021 8:39pm

Instant sales

"We have experienced demand from Canadians on our website that we were unable to fulfill. Through RDT, we can now make our popular aftermarket pods and disposable vaporizers available to Canadian customers. We are also looking forward to bringing continued innovation and new formulations to the market with this partnership with Rapid Dose.”

https://www.globenewswire.com/news-release/2021/03/10/2190883/0/en/Rapid-Dose-Therapeutics-Signs-Production-Agreement-With-OG-Laboratories-to-Produce-Cannabis-Vape-and-CBD-From-Hemp-Products.html
Comment by Mykndrsn on Mar 11, 2021 10:09am
Utilizing obviously available production capacity to manufacture successful products for others just means sales of proprietary products (ie strips) is a failure. This isn't good news, just riding on the success of others who have sales and marketing acumen Dose clearly lacks. 
Comment by bajanjohn on Mar 11, 2021 11:25am
I don't think that there is to much wrong with making money.
Comment by Mykndrsn on Mar 11, 2021 12:39pm
 Neither does OG labs. Successful marketing apparently works. Dose should try it.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities